Marit Otterlei
Founder at APIM Therapeutics AS
Marit Otterlei active positions
Companies | Position | Start | End |
---|---|---|---|
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Chief Tech/Sci/R&D Officer | 31/12/2008 | - |
Founder | 31/12/2008 | - | |
Norwegian University of Science & Technology | Corporate Officer/Principal | - | - |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | 31/12/2005 | - |
Career history of Marit Otterlei
Former positions of Marit Otterlei
Companies | Position | Start | End |
---|---|---|---|
Noregs forskingsråd | Director/Board Member | 31/12/2004 | - |
Training of Marit Otterlei
Norwegian University of Science & Technology | Graduate Degree |
Statistics
International
Norway | 5 |
Operational
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Health Technology |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | Commercial Services |
Noregs forskingsråd | Government |
- Stock Market
- Insiders
- Marit Otterlei
- Experience